Cardiovascular-kidney-metabolic (CKM) syndrome: a state-of-the-art review
"It's because the people we know who are on GLP-1 constantly discontinue and restart their medication," said Emmanuel Rapp a graduate student at Penn's Leung Lab
Motzer RJ, Tannir NM, and McDermott DF, et al (2018) Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma N Engl J Med 378 (14) 12771290 PMID: 29562145 PMCID: 5972549 8
Clinical efficacy and safety The integral part of T2D therapy is to improve the glycaemic control and decrease the incidence of CV diseases
What can you do when all the mainstream diet and exercise plans youve tried in the past havent helped you lose weight
I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)